Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel

Acta Haematologica

Volumn 117, Issue 1, 2006, Pages 57-64

  Ostrovsky, Olga ^a   Korostishevsky, Michael ^b   Levite, Iris ^a   Leiba, Merav ^a   Galski, Hanan ^a   Gazit, Ephraim ^a   Vlodavsky, Israel ^c   Nagler, Arnon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Heparanase; Linkage disequilibrium; Single nucleotide polymorphisms

Indexed keywords

HEPARANASE;

ADULT; ANGIOGENESIS; ARTICLE; CAUCASIAN; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENOTYPE; HEPARANASE GENE; HEREDITY; HUMAN; INFLAMMATION; ISRAEL; JEW; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AFRICA, NORTHERN; AMINO ACID SUBSTITUTION; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; GENE FREQUENCY; GENOTYPE; GLUCURONIDASE; HAPLOTYPES; HUMANS; INTRONS; ISRAEL; JEWS; LINKAGE DISEQUILIBRIUM; MEDITERRANEAN REGION; MIDDLE EAST; MUTATION, MISSENSE; POINT MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33845733186     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096790     Document Type: Article

References (40)

1. Abboud-Jarrous G, Aingorn H, Rangini-Guetta Z, Atzmon R, Elgavish S, Peretz T, Vlodavsky I: Heparanase processing: site-direct mutagenesis, proteolytic cleavage and activation. J Biol Chem 2005;280:13568-13575.
2. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, Schirrmacher V, Mitrani E, Vlodavsky I: Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 2002;99:10031-10036.
3. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michael R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999;5:793-802.
4. Nakajima M, Irimura T, Nicolson GL: Heparanases and tumor metastasis. J Cell Biochem 1988;36:157-167.
5. Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001;108:341-347.
6. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I: Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 2004;96:1219-1230.
7. Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Papo O: Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 2000;157:1167-1175.
8. Koliopanos A, Friess H, Kleeff J, Shi X, Liao O, Pecker I, Vlodavsky I, Zimmermann A, Buchler MW: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001;61:4655-4659.
9. Zcharia E, Metzger S, Chajek-Shaul T, Friedmann Y, Pappo O, Aviv A, Elkin M, Pecker I, Peretz T, Vlodavsky I: Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia 2001;6:311-322.
10. El-Assal ON, Yamanei A, Oho T, Kohno H, Nagasue N: The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res 2001;7:1299-1305.
11. Peretz T, Antebi SU, Beller U, Horowitz AT, Fuks Z, Vlodavsky I: Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens. Int J Cancer 1990;45:1050-1060.
12. Kosir MA, Wang W, Zukowski KL, Tromp G, Barber J: Degradation of basement membrane by prostate tumor heparanase. J Surg Res 1999;81:42-47.
13. Gohji K, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuaka Y, Nakajima M: Heparanase protein and gene expression in bladder cancer. J Urol 2001;166:1286-1290.
14. Rohloff S, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mossner J, Wittekind C, Caca K: Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer 2002;86:1270-1275.
15. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I: Heparanase as mediator of angiogenesis: mode of action. FASEB J 2001;15:1661-1663.
16. Joyce JA, Freeman C, Meyer-Morse N, Parish CR, Hanahan D: A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 2005;24:4037-4051.
17. Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y, MacLeod V, Casciano J, Joseph L, Zhan F, Zangari M, Barlogie B, Shaughnessy J, Sanderson RD: High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 2003;63:8749-8756.
18. Watanabe M, Aola Y, Kase H, Tanaka K: Heparanase expression and angiogenesis in endometrial cancer. Gynecol Obstet Invest 2003;56:77-82.
19. Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D: Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factors. Cancer Metastasis Rev 1996;15:177-186.
20. Dong J, Kukula AK, Toyoshima M, Nakajima M: Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene 2000;253:171-178.
21. Parish CR, Freeman C, Hulett MD: Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001;1471:M99-M108.
22. Abramson JH, Gahlinger PM: Computer Program for Epidemiologists, PEPI, Version 3. London, Brixton Books, 1999.
23. Komlos L, Korostishevsky M, Livni E, Halbrecht I, Vardimon D, Ben-Rafael Z, Klein T: Possible sex-correlated transmission of maternal class I HLA haplotypes. Eur J Immunogenet 1997;24:169-177.
24. Schneider S, Roessli D, Excoffier L: A Software for Population Genetic Data Analysis. Manual Arlequin, Version 2.00. Geneva, University of Geneva, 2000.
25. Nei M: Molecular Evolutionary Genetics. New York, Columbia University Press, 1987.
26. Slatkin M: Linkage disequilibrium in growing and stable population. Genetics 1994;137:331-336.
27. Slatkin M, Excoffier L: Testing for linkage disequilibrium in genotypic data using the EM algorithm. Heredity 1996;76:377-383.
28. Guo S, Thomson E: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-372.
29. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-927.
30. Korostishevsky M, Kremer I, Kaganovich M, Cholostoy A, Murad I, Muhaheed M, Bannoura I, Reitschel M, Dobrusin M, Abu-Shach UB, Belmaker RH, Maier W, Ebstein RP, Navon R: Transmission disequilibrium and haplotype analysis of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in North of Israel. Am J Med Genet B Neuropsychiatr Genet 2006;141:91-95.
31. Takeuchi F, Yanai K, Morii T, Ishinaga Y, Taniguchi-Yanai K, Nagano S, Kato N: Linkage disequilibrium grouping of single nucleotide polymorphisms (SNPs) reflecting haplotype phylogeny for efficient selection of Tag SNPs. Genetics 2005;170:291-304.
32. Hammer MF, Redd AJ, Wood ET, Bonner MR, Jarjanazi H, Karafet T, Jantachiara-Benerecetti S, Oppenheim A, Jobling MA, Jenkins T, Ostrer H, Bonne-Tamir B: Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes. Proc Natl Acad Sci USA 2000;97:6769-6774.
33. Kobyliansky E, Micle S, Goldshmidt-Nathan M, Arensburg B, Nathan H: Jewish populations of the world: genetic likeness and differences. Ann Hum Biol 1982;9:1-34.
34. Ostrovsky O, Nagler A, Korostishevsky M, Gazit E, Galski H: Genotype and allele frequencies of C3435T polymorphism of the MDR1 gene in various Jewish populations of Israel. Ther Drug Monit 2004;26:679-684.
35. Fearnhead P, Smith NGC: A novel method with improved power to detect recombination hotspots from polymorphism data reveals multiple hotspots in human genes. Am J Hum Genet 2005;77:781-794.
36. Zhang J, Li F, Li J, Zhang MQ, Zhang X: Evidence and characteristics of putative human α recombination hotspots. Hum Mol Genet 2004;13:2823-2828.
37. de Mestre AM, Khachigian LM, Santiago FS, Staykova MA, Hulett MD: Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem 2003;278:50377-50385.
38. de Mestre AM, Rao S, Hornby JR, Soe-Htwe T, Khachigian LM, Hulett MD: EGR1 regulates heparanase gene transcription in tumor cells. J Biol Chem 2005;280:35136-35147.
39. Stumpf MPH, Goldstein DB: Demography, recombination hotspot intensity, and the block structure of linkage disequilibrium. Curr Biol 2003;13:1-8.
40. Wall JD, Pritchard JK: Assessing the performance of the haplotype block model of linkage disequilibrium. Am J Hum Genet 2003;73:502-515.